Sign in

CIK 0001739410 · <br>Emerging growth company

Rallybio Corp

Sign in to watch
Ticker
RLYB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851083789
Phone
203- 859-3820
Business address
234 CHURCH STREET, SUITE 1020, NEW HAVEN, CT, 06510
Former names
Rallybio Holdings, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$9,608
in 1 filing

Net −$9,608. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Lieber Jonathan I −$10K Chief Financial Officer sold 4% of stake
Date Insider Transaction Shares Price Value Owned after
2021-07-28 MACKAY MARTIN Chief Executive Officer Other disposition · Series A-1 Preferred Units −150,000 0
2021-07-28 MACKAY MARTIN Chief Executive Officer Other disposition · Series A-2 Preferred Units −100,000 0
2021-07-28 MACKAY MARTIN Chief Executive Officer Other disposition · Series B Preferred Units −107,891 0
2021-07-28 MACKAY MARTIN Chief Executive Officer Grant or award · Option (Right to Buy) +160,000 160,000
2021-07-28 Fryer Jeffrey M See Remarks Other acquisition +32,648 32,648
2021-07-28 Fryer Jeffrey M See Remarks Other acquisition +272,609 272,609
2021-07-28 Fryer Jeffrey M See Remarks Other acquisition +201,934 201,934
2021-07-28 Fryer Jeffrey M See Remarks Other acquisition +201,934 201,934
2021-07-28 Fryer Jeffrey M See Remarks Other disposition · Common Units −2,255,000 0
2021-07-28 Fryer Jeffrey M See Remarks Other disposition · Common Units −1,282,500 0
2021-07-28 Fryer Jeffrey M See Remarks Other disposition · Common Units −1,282,500 0
2021-07-28 Fryer Jeffrey M See Remarks Other disposition · Series A-1 Preferred Units −75,000 0
2021-07-28 Fryer Jeffrey M See Remarks Other disposition · Series A-1 Preferred Units −75,000 0
2021-07-28 Fryer Jeffrey M See Remarks Other disposition · Series A-2 Preferred Units −100,000 0
2021-07-28 Fryer Jeffrey M See Remarks Other disposition · Series B Preferred Units −107,891 0
2021-07-28 Fryer Jeffrey M See Remarks Grant or award · Option (Right to Buy) +160,000 160,000
2021-07-28 PARMAR KUSH Director Other acquisition +2,784,626 2,784,626
2021-07-28 PARMAR KUSH Director Other acquisition +790,714 790,714
2021-07-28 PARMAR KUSH Director Other disposition · Series A-1 Preferred Units −1,795,946 0
2021-07-28 PARMAR KUSH Director Other disposition · Series A-2 Preferred Units −8,742,654 0

Page 10 of 11 · 216 trades